Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christoph Roggel"'
Autor:
Benjamin Heidrich, Hans-Jörg Cordes, Hartwig Klinker, Bernd Möller, Uwe Naumann, Martin Rössle, Michael R Kraus, Klaus H Böker, Christoph Roggel, Marcus Schuchmann, Albrecht Stoehr, Andreas Trein, Svenja Hardtke, Andrea Gonnermann, Armin Koch, Heiner Wedemeyer, Michael P Manns, Markus Cornberg
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128069 (2015)
Although sofosbuvir has been approved for patients with genotypes 2/3 (G2/3), many parts of the world still consider pegylated Interferon alpha (P) and ribavirin (R) as standard of care for G2/3. Patients with rapid virological response (RVR) show re
Externí odkaz:
https://doaj.org/article/480fc8c9512e41d4bac4e086b6db9929
Autor:
Klaus H.W. Böker, Hans-Jörg Cordes, Andrea Gonnermann, Michael P. Manns, Christoph Roggel, Markus Cornberg, Albrecht Stoehr, Hartwig Klinker, Marcus Schuchmann, Benjamin Heidrich, Armin Koch, Bernd Möller, Michael R. Kraus, Heiner Wedemeyer, Svenja Hardtke, A. Trein, U Naumann, Martin Rössle
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128069 (2015)
PLoS ONE
PLoS ONE
UNLABELLED Although sofosbuvir has been approved for patients with genotypes 2/3 (G2/3), many parts of the world still consider pegylated Interferon alpha (P) and ribavirin (R) as standard of care for G2/3. Patients with rapid virological response (R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3121f0c4d334ae30c109160d64e432fd
https://doi.org/10.1371/journal.pone.0128069
https://doi.org/10.1371/journal.pone.0128069